Artivion (AORT)

• Market cap: $1.04B
• 1 day: 1.26%
• 5 days: 0.93%
• 1 month: -0.96%
• 3 months: -11.36%
• 6 months: -5.25%
• Year to date: -11.36%
• 1 year: 17.46%
• 5 years: 52.33%
• 10 years: 142.12%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

Employees: 1,500

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

1,252% more call options, than puts

Call options by funds: $892K | Put options by funds: $66K

13% more capital invested

Capital invested by funds: $964M [Q3] → $1.09B (+$127M) [Q4]

4.97% more ownership

Funds ownership: 86.43% [Q3] → 91.4% (+4.97%) [Q4]

5% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 22

1% more funds holding

Funds holding: 172 [Q3] → 173 (+1) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

3% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 58

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $30 21% upside
• Avg. target: $32 27% upside
• High target: $33 33% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Citizens Capital Markets Daniel Stauder 10% 1-year accuracy 1 / 10 met price target	33% upside $33	Market Outperform Reiterated	25 Feb 2025
Stifel Rick Wise 43% 1-year accuracy 15 / 35 met price target	21% upside $30	Buy Maintained	25 Feb 2025
Needham Mike Matson 40% 1-year accuracy 50 / 124 met price target	29% upside $32	Buy Maintained	25 Feb 2025